Peresolimab: Phase 2 Study for Rheumatology Treatment May 18, 2023 by Alexandra Hartman Editor-in-Chief 2023-05-18 09:14:28 Rheumatology – Phase 2 study Phase 2 study The monoclonal antibody peresolimab restores the immune checkpoint in rheumatoid arthritis. Biomarkers and predictive factors for rheumatoid arthritis continue to be studied. (ILLUSTRATION: Gabriel Sanz) 1684401403 #explore #checkpoint #route #treat #rheumatoid #arthritis Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Alexandra Hartman Editor-in-Chief Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.
